Meet
Lilian Buch

Lilian Buch guides the development of innovative market access and patient support strategies to align with the client's priorities and goals

Prior to joining Avalere, Lilian was a senior access and reimbursement manager with Bristol Myers Squibb where she supported and executed patient access program strategies for oncology, rheumatology, and transplant portfolios.

She is passionate about providing solutions and removing hurdles to coverage, coding, and reimbursement with a focus on optimizing outcomes for patients, providers, and payer stakeholders.

Lilian has over 20 years of experience in the pharmaceutical industry.  She has successfully launched orphan, immuno-oncology, and autoimmune drugs, and has expertise in commercial payer medical policy and utilization management, Medicare payment models, and impact of healthcare policy on patient access.

Lilian earned a BA in biology from the University of Northern Iowa and is a Certified Professional Biller.

Authored Content


In November 2020, the Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) to COVID-19 monoclonal antibodies for treatment of mild-to-moderate COVID-19 infection.

Tune into another episode in the Avalere Health Essential Voice series focused on disease education. In this segment, experts from Community Oncology Alliance (COA) and Texas Oncology join us to discuss the impact of COVID-19 on oncology care from a provider and patient perspective.

Tune into another episode in the Avalere Health Essential Voice podcast series focused on disease education. In this segment, experts from Community Oncology Alliance (COA) and Texas Oncology join us to discuss the impact of COVID-19 on oncology care from a provider and patient perspective.

Tune into the second segment of the Avalere Health Essential Voice series focused on disease education. In this segment, experts from our Market Access practice discuss rare disease patient support programs and the need for stakeholder partnerships to address many of the barriers patients and their caregivers face.

Tune into the second segment of the Avalere Health Essential Voice podcast series focused on disease education. In this segment, experts from our Market Access practice discuss rare disease patient support programs and the need for stakeholder partnerships to address many of the barriers patients and their caregivers face.